ARSYNL Rx review

ARSYNL publishes monthly and prepaid sermorelin and NAD⁺ plans. Sermorelin includes medication, follow-up labs and provider check-ins as advertised, while baseline testing costs need confirmation. The FAQ names pharmacy and clinical partners, but money-back marketing remains in tension with the prescription final-sale policy.

ARSYNL Rx is a veteran-founded multi-service telehealth platform operated by ARSYNL LLC, with a Dover, Delaware address, and founded by U.S. Army veteran Arron Glysch. Its longevity line carries sermorelin, NAD⁺ by injection and nasal spray, glutathione and MIC-B12; alongside that it runs testosterone therapy including a needle-free HypoSpray, enclomiphene, sexual health, hair restoration, metformin, low-dose naltrexone and compounded GLP-1 weight-loss care. It says it is LegitScript-certified, and a portion of revenue goes to a veterans' recovery nonprofit.

The FAQ describes MD Integrations and names Manifest Pharmacy and RX Compounding Store as partners. These are seller disclosures, not independently verified credentials or your assigned clinician and pharmacy. Service is for adults 18 and older, with therapy- and state-specific restrictions; some states require live chat or video.

The sermorelin offer advertises follow-up labs and provider check-ins as included. Confirm baseline testing costs and monitoring for your particular therapy rather than assuming every plan has the same inclusions.

Sermorelin is $169.99 billed monthly or $480 prepaid for three months, with medication and advertised follow-up labs and provider check-ins included. NAD⁺ injection is $149 monthly or $419 prepaid for three months; its primary plan block does not establish a twelve-month option. Separately, nasal NAD⁺ is $179 monthly, $449 for three months or $1,559 for twelve months.

Daily transdermal testosterone HypoSpray is $239 monthly, $657 for three months or $2,148 for twelve months. These route-specific plans are not injectable TRT prices. Confirm baseline lab charges, prescribed supply and the selected renewal schedule.

The FAQ says billing occurs when medication ships. Cancel or change the account before shipping, and contact the service before refill billing. Charged prescriptions are final after carrier handoff despite product-page money-back marketing. Support handles damaged or lost packages, including reshipment for loss. Refunds for medical denial or unshipped prepaid periods are not established; obtain any guarantee exception in writing.

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. Sermorelin, NAD⁺, glutathione and the GLP-1 products are compounding-pharmacy preparations, not therapeutically equivalent to branded drugs; naming the pharmacies gives you something to check. On the evidence, the longevity line splits cleanly. Sermorelin acts on the growth-hormone axis, a genuine mechanism with thin long-term outcome data and no controlled trial demonstrating the recovery or body-composition benefits it is marketed for. Injectable and intranasal NAD⁺ have no controlled human outcome trials; the oral precursors NR and NMN are the forms with human data, and that data establishes a raised blood NAD⁺ level rather than a clinical benefit. Injectable glutathione has essentially no controlled human outcome evidence for the wellness claims attached to it. Separately, if you take up the testosterone line as well, note that testosterone therapy carries real monitoring requirements, hematocrit, PSA and lipids among them, and suppresses fertility, which is the single most under-discussed consequence in this market. Individual results vary.